Stockreport

Aytu BioPharma, Inc. (NASDAQ:AYTU) Q2 2024 Earnings Call Transcript [Yahoo! Finance]

Aytu BioPharma, Inc.  (AYTU) 
NASDAQ:AMEX Investor Relations: aytubio.com/investors/stock-information
PDF Reported EPS is $-0.04, expectations were $-0.25. Aytu BioPharma, Inc. isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter ( see th [Read more]